Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.84 EUR | +0.09% | -.--% | -.--% |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 8.74B | - | ||
-3.78% | 1.39B | D | ||
-4.71% | 1.2B | - | ||
-28.62% | 764M | - | - | |
-.--% | 619M | - | - | |
+7.56% | 467M | - | ||
+2.04% | 435M | - | - | |
-33.42% | 297M | - | - | |
-62.96% | 262M | - | ||
+1.17% | 216M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.